FOXO signs $2M equity facility with ClearThink, receives USPTO patent for ML epigenetic biomarkers

FOXO TECHNOLOGIES INC.

Equity line agreement with ClearThink for up to $2M of common stock at 85% of lowest 10-day VWAP; 1M commitment shares.
Securities Purchase Agreement for 2M restricted shares at $200,000 ($0.10/share) in two closings; subject to price adjustment if registration delayed.
USPTO issues patent for machine learning model trained on DNA epigenetic data to determine biochemical states and medical conditions.
Corrected Shares for Services Agreement with Joseph Gunnar removes inadvertently included convertible securities and fundamental transaction provisions.

item 1.01 item 8.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

FOXO TECHNOLOGIES INC. entered into Securities Purchase Agreement with ClearThink Capital Partners, LLC valued at $200,000 (effective 2023-10-13).

Action: entry
Agreement: equity purchase
Counterparty: ClearThink Capital Partners, LLC
Value: $200,000
Effective: 2023-10-13

Exact text from the filing

Concurrently with the execution of the Strata Purchase Agreement, the Company and ClearThink also entered into a Securities Purchase Agreement (the “SPA”) under which ClearThink has agreed to purchase from the Company an aggregate of 2,000,000 restricted shares of Common Stock for a total purchase price of $200,000 in two closings.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

FOXO TECHNOLOGIES INC. entered into Registration Rights Agreement with ClearThink Capital Partners, LLC (effective 2023-10-13).

Action: entry
Counterparty: ClearThink Capital Partners, LLC
Effective: 2023-10-13

Exact text from the filing

In connection with the Strata Purchase Agreement, the Company entered into a Registration Rights Agreement with ClearThink under which the Company agreed to file, within 60 days of executing definitive documents, a registration statement (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) covering the shares of Common Stock issuable under the Strata Purchase Agreement (the “Registration Rights Agreement”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

FOXO TECHNOLOGIES INC. entered into Strata Purchase Agreement with ClearThink Capital Partners, LLC valued at $2,000,000 (effective 2023-10-13).

Action: entry
Agreement: equity purchase
Counterparty: ClearThink Capital Partners, LLC
Value: $2,000,000
Effective: 2023-10-13

Exact text from the filing

On October 13, 2023, FOXO Technologies Inc. (the “Company”) entered into a Strata Purchase Agreement (the “Strata Purchase Agreement”) with ClearThink Capital Partners, LLC (“ClearThink”)

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

FOXO TECHNOLOGIES INC. filing history →

Source: SEC EDGAR

accession 0001013762-23-004115

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.